Sangamo Therapeutics (SGMO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -257,831 | -192,278 | -178,297 | -121,122 | -95,419 |
| Depreciation Amortization | 109,348 | 19,320 | 20,482 | 12,544 | 4,899 |
| Income taxes - deferred | -6,335 | 0 | 0 | N/A | N/A |
| Accounts receivable | 3,147 | 1,890 | -103 | 31,332 | -32,543 |
| Other Working Capital | -164,034 | -82,319 | -101,895 | 252,586 | -73,010 |
| Other Operating Activity | 90,863 | 29,760 | 26,562 | -5,465 | 51,671 |
| Operating Cash Flow | $-224,842 | $-223,627 | $-233,251 | $169,875 | $-144,402 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 174,686 | 79,456 | 271,596 | -256,209 | -38,864 |
| PPE Investments | -21,155 | -20,171 | -23,278 | -14,714 | -20,675 |
| Purchase Of Investment | 0 | 0 | -119 | -704 | -262 |
| Investing Cash Flow | $153,531 | $59,285 | $248,199 | $-271,627 | $-59,801 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 16,041 | 86,764 | 36,116 | 153,865 | 142,451 |
| Other Financing Activity | -1,453 | -2,104 | -3,258 | -765 | -422 |
| Financing Cash Flow | $14,588 | $84,660 | $32,858 | $153,100 | $142,029 |
| Exchange Rate Effect | 1,483 | 1,254 | -263 | -447 | 184 |
| Beginning Cash Position | 101,944 | 180,372 | 132,829 | 81,928 | 143,918 |
| End Cash Position | 46,704 | 101,944 | 180,372 | 132,829 | 81,928 |
| Net Cash Flow | $-55,240 | $-78,428 | $47,543 | $50,901 | $-61,990 |
| Free Cash Flow | |||||
| Operating Cash Flow | -224,842 | -223,627 | -233,251 | 169,875 | -144,402 |
| Capital Expenditure | -21,155 | -20,171 | -23,278 | -14,714 | -20,675 |
| Free Cash Flow | -245,997 | -243,798 | -256,529 | 155,161 | -165,077 |